Perimenopause, mood, and "brain fog": what's real and what helps

The mood shift is real and measurable

Across studies of more than a million women, roughly one in three report depressive symptoms during the menopause transition. The risk is not uniform: women with a prior episode of depression carry the most — their risk of recurrence more than doubles during the transition. A 2024 Lancet review is equally clear on the other side: most women move through perimenopause without developing a mood disorder, so symptoms deserve evaluation, not assumption.

Hot flashes, sleep, and mood feed each other

Large longitudinal studies show vasomotor symptoms (hot flashes, night sweats), sleep disruption, and mood changes each roughly double the odds of the others — and sleep disturbance appears to carry much of the link between night-time symptoms and low mood. Practically, that makes night symptoms and sleep one of the most useful treatment targets in midlife mood care.

"Brain fog" is common — and usually transient

Forgetfulness and concentration trouble are among the most frequently reported perimenopausal symptoms. Meta-analyses find modest, measurable cognitive differences during the transition that generally do not persist afterward, and imaging studies show the brain actively adapting. Cognitive complaints still warrant review — sleep, mood, medications, and medical factors can all contribute.

What helps, according to guidelines

Standard psychiatric treatment remains first-line: psychotherapy and, when appropriate, antidepressants — some of which can ease both mood and hot flashes. CBT is specifically recommended by NICE and The Menopause Society. Hormone therapy has real but bounded roles: it is not approved for treating depression and helps mood mainly when bothersome hot flashes co-occur. Foundry weighs the hormonal and medical context inside psychiatric care and coordinates with gynecology or primary care when hormone-side decisions belong there.

Related service